Author details

Full Name

Qiushi Tang

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36854773	The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.		2023
36307645	The application of single-cell sequencing in pancreatic neoplasm: analysis, diagnosis and treatment.	British Journal of Cancer	2023
36092924	Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature.	Frontiers in Genetics	2022
35835409	Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.	Cancer Letters	2022
33986612	Hub Genes Associated with the Diagnosis of Diabetic Retinopathy.	International Journal of General Medicine	2021
32607885	Engraftment of Human Hepatocytes in the PiZ-NSG Mouse Model.	Methods in Molecular Biology	2020
33117614	Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.		2020
30828586	Bridging from Intramuscular to Limb Perfusion Delivery of rAAV: Optimization in a Non-human Primate Study.	Molecular Therapy - Methods and Clinical Development	2019
29597895	In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.	Hum Gene Ther	2018
29032169	Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of Î±-1 Antitrypsin Deficiency.	Mol Ther	2017
28752462	Quantification of Z-AAT by a Z-Specific "Sandwich" ELISA.	Methods in Molecular Biology	2017
28752460	Quantification of Total Human Alpha-1 Antitrypsin by Sandwich ELISA.	Methods in Molecular Biology	2017
26403887	Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.	Mol Ther	2015
24231351	Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.	J Clin Invest	2013
22252449	Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles.	Molecular Therapy	2012
22395529	Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.	Mol Ther	2012
19935781	Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e.	Molecular Therapy	2010
18818669	The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model.	Gene Therapy	2009
18941444	Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery.	Mol Ther	2009
18720429	Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient mice.	Journal of Gene Medicine	2008
17592477	In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.	Lab Invest	2007
16518879	Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.	Journal of Gene Medicine	2006
15979413	Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts.	Mol Ther	2005
14712302	Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.	Gene Therapy	2004
15353038	Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.	Human Gene Therapy	2004
14766968	DNA-dependent PK inhibits adeno-associated virus DNA integration.	Proceedings of the National Academy of Sciences of the United States of America	2004
12907946	Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver.	Gene Ther	2003